ChemoCentryx (CCXI) Pushes Into Positive Territory; Alphabet Inc. (GOOG, GOOGL) Outperforms on Judge’s Ruling


ChemoCentryx, Inc. (Nasdaq:CCXI) stock soared to touch the $5.60 mark throughout the course of Friday’s market activity, finally closing at $5.20, up $0.78 (or +17.65%) with a total volume of 3,659,838 shares traded during the day. There was no news from the company driving the stock higher.

The clinical-stage biopharmaceutical company will present at the Jefferies 2016 Healthcare Conference on June 8, 2016.

ChemoCentryx has $44.29M Shares Outstanding, Market Capitalization (intraday) of $230.31M and CCXI stock one-year range is from $1.92 to $9.46 per share



Shares of Alphabet Inc. (Nasdaq:GOOG) (Nasdaq:GOOGL) surged after a judge ruled in Google’s favor in a copyright infringement and software licensing dispute with database giant Oracle Corp. (NYSE:ORCL).

A federal jury found that the use of parts of Oracle’s Java programming language in Google’s Android was a “fair use” under copyright law

GOOG stock closed at $732.66, up $8.54 (or +1.18%), while GOOGL shares climbed $10.67 (or +1.45%) to $747.60 on Friday’s trading session

Alphabet is the parent holding company of Google. It has 343.44M Shares Outstanding of GOOG and 293.68M Shares Outstanding of GOOGL. The 52-week range for GOOG stock is from $515.18 to $789.87, while for GOOGL stock is between $538.85 and $810.35 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at